Tectorigenin

Tectorigenin

SCHEMBL2074313

COc1c(O)cc2occ(-c3ccc(O)cc3)c(=O)c2c1O.O=c1c(-c2ccccc2)coc2ccccc12

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.80
ALDH2 P05091 2/20 0.56
HDAC6 Q9UBN7 4/20 0.55
ALDH1A1 P00352 8/20 0.55
CYP3A4 P08684 7/20 0.55
MAPT P10636 7/20 0.55
HPGD P15428 7/20 0.55
KDM4E B2RXH2 6/20 0.54
POLB P06746 3/20 0.54
XDH P47989 2/20 0.54
SMN1; SMN2 Q16637 8/20 0.53
NPC1 O15118 6/20 0.53
RAB9A P51151 6/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MEN1 O00255 6/20 0.52
KMT2A Q03164 6/20 0.52
TP53 P04637 6/20 0.52
HSD17B10 Q99714 4/20 0.52
ALOX15 P16050 3/20 0.52
ALOX12 P18054 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tectorigenin SCHEMBL351641 0.89 EGFR (1.00) EGFRALDH2HDAC6ALDH1A1CYP3A4
Tectorigenin SCHEMBL29353966 0.89 EGFR (1.00) EGFRALDH2HDAC6ALDH1A1CYP3A4
Glycitein SCHEMBL869704 0.82 HDAC6 (0.83) EGFRALDH2HDAC6ALDH1A1CYP3A4
Genistein SCHEMBL554356 0.82 SMN1; SMN2 (0.79) EGFRALDH2HDAC6ALDH1A1CYP3A4
SCHEMBL7760758 0.82 EGFR (0.76) EGFRALDH2ALDH1A1CYP3A4MAPT
Irisolidone SCHEMBL30997344 0.81 EGFR (0.84) EGFRALDH2HDAC6ALDH1A1CYP3A4
Irisolidone SCHEMBL1974327 0.81 EGFR (0.84) EGFRALDH2HDAC6ALDH1A1CYP3A4
Isoflavone SCHEMBL3066716 0.80 ALOX12 (0.80) EGFRALDH2HDAC6ALDH1A1CYP3A4
Tectoridin SCHEMBL18586434 0.80 ALDH1A1 (0.66) EGFRALDH2ALDH1A1CYP3A4MAPT
Irilin D SCHEMBL571722 0.79 EGFR (0.80) EGFRALDH2ALDH1A1CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107216243-B Chalcone analogue and preparation method and application thereof 四川省中医药科学院 2020-08-28 CN disclosed
US-7902253-B2 Isoflavone derivatives of tectorigenin, the preparation thereof and the antiviral medicine containing the same as an effective constituent CHENGDU DIKANG PHARMACEUTICAL INSTITUTE (CN) 2011-03-08 US disclosed
EP-1630160-B1 THE ISOFLAVONE DERIVATIVES OF TECTORIDIN, THE PREPARATION THEREOF AND THE ANTI-VIRUS MEDICINES CONTAINING THE SAME AS THE EFFECTIVE CONSTITUENTS CHENGDU DIKANG PHARMACEUTICAL (CN) 2009-04-08 EP disclosed
US-20070123566-A1 Isoflavone derivatives of tectoridin, the preparation thereof and the anti-virus medicines containing the same as an effective constituents CHENGDU DIKANG PHARMACEUTICAL INSTITUTE (CN) 2007-05-31 US disclosed
EP-1630160-A1 THE ISOFLAVONE DERIVATIVES OF TECTORIDIN, THE PREPARATION THEREOF AND THE ANTI-VIRUS MEDICINES CONTAINING THE SAME AS THE EFFECTIVE CONSTITUENTS Chengdu Dikang Pharmaceutical Institute (CN) 2006-03-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123566-A1 Isoflavone derivatives of tectoridin, the preparation thereof and the anti-virus medicines containing the same as an effective constituents CCNE2, TEC, NFE2 EGFR 1446/4885ALDH2 4491/4885HDAC6 3015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.